These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6194925)

  • 1. Influence of season and anaesthetic on cutaneous vascular permeability responses to histamine, serotonin and mast cell-releasing agents in rats.
    Chahl LA
    Clin Exp Pharmacol Physiol; 1983; 10(4):415-20. PubMed ID: 6194925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of laboratory anaesthetics on the increased cutaneous vascular permeability responses to histamine and 5-hydroxytryptamine in rats.
    O'Duffy G; Chahl LA
    J Pharmacol Methods; 1980 Nov; 4(3):231-5. PubMed ID: 7442268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the interaction between H1- and H2-histaminergic receptors in the histamine release and the realization of its vascular effects in rat skin.
    Belcheva A; Zhelyazkova M
    Acta Physiol Pharmacol Bulg; 1988; 14(4):49-54. PubMed ID: 2469294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of mast cell degranulation and subsequent stimulation of histamine H1 and H2 receptors in radiographic contrast media-increased vascular permeability in rats.
    Goromaru T; Sendo T; Itoh Y; Sakai N; Teshima D; Oishi R
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):605-12. PubMed ID: 12444503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). II. Mechanism of antiallergic action of TA-5707.
    Tsuzurahara K; Ishikawa S; Ono Y; Murata T; Kikuchi M; Takeyama S
    Jpn J Pharmacol; 1987 Sep; 45(1):55-62. PubMed ID: 2446038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. II. Dermovascular permeability-increasing effect and action on peritoneal mast cells.
    Furuhata K; Fukuda Y; Soumi K; Arai H; Watanabe Y; Narita H
    Biol Pharm Bull; 1998 May; 21(5):461-4. PubMed ID: 9635500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of Histamine H1- and H2-receptors in cutaneous inflammation in the guinea-pig produced by histamine and mast cell degranulation.
    Owen DA; Poy E; Woodward DF; Daniel D
    Br J Pharmacol; 1980 Aug; 69(4):615-23. PubMed ID: 6108140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on cutaneous vascular permeability in the rat: increases caused by histamine and histamine-like agents.
    Owen DA; Pipkin MA; Woodward DF
    Agents Actions; 1984 Jan; 14(1):39-42. PubMed ID: 6230901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.
    Richardson PD; Withrington PG
    Br J Pharmacol; 1977 May; 60(1):123-33. PubMed ID: 884383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological analysis of salivary and blood flow responses to histamine of the submandibular gland of the dog.
    Shimizu T; Taira N
    Br J Pharmacol; 1980 Apr; 68(4):651-61. PubMed ID: 7378641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of LY53857, a selective 5HT2 receptor antagonist, on 5HT-induced increases in cutaneous vascular permeability in rats.
    Cohen ML; Schenck K
    Life Sci; 1989; 44(14):957-61. PubMed ID: 2927252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular permeability in allergic conjunctivitis in mice lacking histamine H1 receptors.
    Nakahara H; Izushi K; Sugimoto Y; Watanabe T; Kamei C
    Eur J Pharmacol; 2000 Dec; 409(3):313-7. PubMed ID: 11108826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microvascular regulatory mechanisms. III. Aminergic mechanisms as related to mast cells.
    Reilly FD; Dimlich RV; Cilento EV; McCuskey RS
    Int J Microcirc Clin Exp; 1983; 2(1):61-73. PubMed ID: 6678839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin.
    Iuvone T; Den Bossche RV; D'Acquisto F; Carnuccio R; Herman AG
    Br J Pharmacol; 1999 Oct; 128(3):700-4. PubMed ID: 10516651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some studies of the action of betahistine at H1 and H2 receptors for histamine.
    Gater PR; Webber SE; Gui GP; Jordan CC; Hayes NA; Ashford JJ; Foreman JC
    Agents Actions; 1986 Jun; 18(3-4):342-50. PubMed ID: 2428222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell.
    Shibata H; Minami E; Hirata R; Mizutani N; Nabe T; Kohno S
    Inflamm Res; 2000 Oct; 49(10):553-9. PubMed ID: 11089909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80.
    McLeod RL; Mingo GG; Kreutner W; Hey JA
    Life Sci; 2005 Mar; 76(16):1787-94. PubMed ID: 15698856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-derived vasoactive peptides release histamine.
    Eriksson M; Saldeen K; Saldeen T; Strandberg K; Wallin R
    Int J Microcirc Clin Exp; 1983; 2(4):337-45. PubMed ID: 6206010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.